Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

T3 Pharmaceuticals Ag

Clinical trials sponsored by T3 Pharmaceuticals Ag, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Bacteria injected into tumors: a new weapon against cancer? Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Bacteria injected into tumors: a new weapon against cancer?

Disease control Recruiting now

This early-stage trial tests a genetically modified version of the Yersinia enterocolitica bacterium, given alone or with the immunotherapy pembrolizumab, in 100 adults with advanced solid tumors that have no standard treatment options. The goal is to find a safe dose and see if …

Phase 1/2 • Sponsor: T3 Pharmaceuticals AG • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC